BROOKS LABORATORIES
Back to Cashflow Statement
|
BROOKS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹0.17 Cr | ₹42 Cr | ₹9.72 Cr | ₹11 Cr | ₹64 Cr |
What is the latest Cash Flow from Financing Activities ratio of BROOKS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹0.17 Cr |
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹9.72 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹64 Cr |
How is Cash Flow from Financing Activities of BROOKS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.17 Cr | -99.60 | |
| Mar2025 | ₹42 Cr | 336.45 | |
| Mar2024 | ₹9.72 Cr | -14.83 | |
| Mar2023 | ₹11 Cr | -82.19 | |
| Mar2022 | ₹64 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BROOKS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BROOKS LABORATORIES | ₹162.8 Cr | -6.4% | -17.6% | -61% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
BROOKS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BROOKS LABORATORIES | -6.4% |
-17.6% |
-61% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses